Evidence map›Paper›PMID 32931655›Full record

ArticleCurrent protocols in immunology2020

Immunopharmacology and Quantitative Analysis of Tyrosine Kinase Signaling.

Ben F Brian, Candace R Guerrero, Tanya S Freedman

Open access · hybridAbstract read
In one paragraph

Article in Current protocols in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Regulation of myeloid-cell activation.Current opinion in immunology · 2021
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ben F BrianDepartment of Pharmacology, University of Minnesota, Minneapolis, Minnesota.
Candace R GuerreroCollege of Biological Sciences Center for Mass Spectrometry and Proteomics, University of Minnesota, Minneapolis, Minnesota.
Tanya S FreedmanDepartment of Pharmacology, University of Minnesota, Minneapolis, Minnesota.
University of Minnesota System · USUniversity of Minnesota · US

Funding

Training in PharmacoNeuroImmune Substance Abuse ResearchT32DA007097 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MOLITOR, THOMAS WILLIAM · 1985 to 2021
$13.1M
ACADEMIC RHEUMATOLOGY AND CLINICAL IMMUNOLOGYT32AR007304 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DAIKH, DAVID I · 1986 to 2018
$6.0M
Roles of the Src-Family Kinases LynA and LynB in Macrophage Inflammatory SignalingR01AR073966 · NIAMS · UNIVERSITY OF MINNESOTA · PI FREEDMAN, TANYA S. · 2018 to 2022
$2.2M
Generating LynA-/- and LynB-/- mice by CRISPR/Cas9 genome editingR03AI130978 · NIAID · UNIVERSITY OF MINNESOTA · PI FREEDMAN, TANYA S. · 2017 to 2018
$153k
Regulation of the hematopoietic-cell transmembrane phosphatases CD45 and CD148F32AI082926 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FREEDMAN, TANYA S. · 2009 to 2010
$102k
NIAID NIH HHS F32 AI082926NIAID NIH HHS R03 AI130978NIAMS NIH HHS R01 AR073966NIAMS NIH HHS T32 AR007304NIDA NIH HHS T32 DA007097
6 · The paper itself

Abstract

In this article we describe the use of pharmacological and genetic tools coupled with immunoblotting (Western blotting) and targeted mass spectrometry to quantify immune signaling and cell activation mediated by tyrosine kinases. Transfer of the ATP γ phosphate to a protein tyrosine residue activates signaling cascades regulating the differentiation, survival, and effector functions of all cells, with unique roles in immune antigen receptor, polarization, and other signaling pathways. Defining the substrates and scaffolding interactions of tyrosine kinases is critical for revealing and therapeutically manipulating mechanisms of immune regulation. Quantitative analysis of the amplitude and kinetics of these effects is becoming ever more accessible experimentally and increasingly important for predicting complex downstream effects of therapeutics and for building computational models. Secondarily, quantitative analysis is increasingly expected by reviewers and journal editors, and statistical analysis of biological replicates can bolster claims of experimental rigor and reproducibility. Here we outline methods for perturbing tyrosine kinase activity in cells and quantifying protein phosphorylation in lysates and immunoprecipitates. The immunoblotting techniques are a guide to probing the dynamics of protein abundance, protein-protein interactions, and changes in post-translational modification. Immunoprecipitated protein complexes can also be subjected to targeted mass spectrometry to probe novel sites of modification and multiply modified or understudied proteins that cannot be resolved by immunoblotting. Together, these protocols form a framework for identifying the unique contributions of tyrosine kinases to cell activation and elucidating the mechanisms governing immune cell regulation in health and disease. © 2020 The Authors. Basic Protocol 1: Quantifying protein phosphorylation via immunoblotting and near-infrared imaging Alternate Protocol: Visualizing immunoblots using chemiluminescence Basic Protocol 2: Enriching target proteins and isolation of protein complexes by immunoprecipitation Support Protocol: Covalent conjugation of antibodies to functionalized beads Basic Protocol 3: Quantifying proteins and post-translational modifications by targeted mass spectrometry.

Indexed as

Biological AssayBlotting, WesternCarrier ProteinsHumansImmunologic FactorsImmunomodulationImmunoprecipitationMass SpectrometryMolecular ImagingMultiprotein ComplexesPhosphorylationProtein BindingProtein Processing, Post-TranslationalProtein-Tyrosine KinasesSignal TransductionCarrier ProteinsImmunologic FactorsMultiprotein ComplexesProtein-Tyrosine Kinasesimmunopharmacologyphosphorylationprotein tyrosine kinasequantitative immunoblottargeted mass spectrometryWestern blot

Identifiers

PMID32931655
PMCPMC7583487
OpenAlexW3086215658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.